- This event has passed.
180 Days. To Die. To Live. – November 10, 2024
180 Days. To Die. To Live is the story of two peoples’ end-of-life trajectories through the lens of the narrator. Focused on their last six months, the narrator’s husband, Richard, and her friend, Shelley, were both diagnosed with pancreatic cancer. Richard chose seven rounds of chemotherapy treatment. Shelley chose no treatment. Both opted to use California’s end-of-life option.
Although legalized in California in 2016, many Californians still don’t know the end-of-life option exists. Through these stories, the play also addresses what it takes to be eligible for this option and the sometimes difficult navigation through the healthcare system.
The seemingly somber, “comic” relief is provided by the narrator, the widow, a cancer survivor herself, who is busy learning qigong and other modalities to do her best to stay cancer free and healthy during and through her grief-stricken time. Ultimately, this play is about the choices faced and possible during one’s end-of-life, traversing the personal, to the health care options and to the legalities.
Members of End of Life Choices California’s Board of Directors will participate in post-performance talkback sessions with the audience and cast of the play.
- November 10 – Stewart Florsheim, Board Vice President
- November 16 – Adrian Byram, Board Secretary
- November 22 – Bob Brody, MD, Board President
- December 1 – Reina Galanes, PhD, Board Member
- December 7 – Sue Gess, PharmD, Advisory Council
- December 8 – Judith Bishop, RN, Volunteer
Cost:
General Admission = $25-35 (sliding scale)
Reserved Seating = $50-100
Discount Code = EOL for $20 tickets
Box Office (tickets by phone):
415-282-3055
Mon-Fri 1:00-4:00 PM
Questions: Contact Speaker@endoflifechoicesca.org